Gene expression changes in HLA mismatched mixed lymphocyte cultures reveal genes associated with allorecognition

Tissue Antigens
V NicolaidouP Costeas

Abstract

Human leucocyte antigen (HLA) compatibility is the main factor determining the occurrence of graft-vs-host disease (GVHD) in patients. It has also been shown that minor histocompatibility antigen differences as well as genetic polymorphisms that are not sequenced by standard methodology for HLA typing can play a role. We used mixed lymphocyte cultures (MLCs) as a functional cellular test and investigated gene expression changes driven by HLA incompatibility in an effort to better understand the mechanisms involved in the disease. Gene expression profile of HLA matched and HLA mismatched MLC identified differentially regulated genes and pathways. We found that a great number of genes related to immune function were differentially regulated; these genes were also found to be associated with GVHD and graft rejection. The majority of differentially regulated genes were interferon-gamma (IFNγ)-inducible genes and IFNγ neutralisation in MLCs abrogated their induction. The microRNA-155, a recently identified target for acute GVHD (aGVHD), was also found to be significantly induced in HLA mismatched MLC but not in the matched setting and its induction was not diminished by blocking IFNγ. In this proof-of-principle study we show gene ex...Continue Reading

References

Dec 26, 2001·The New England Journal of Medicine·E W PetersdorfC Anasetti
Mar 28, 2003·Genes, Chromosomes & Cancer·Anke van den BergSibrand Poppema
Jun 23, 2004·Advances in Experimental Medicine and Biology·Francesca FallarinoPaolo Puccetti
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Roman PuliaevCharles S Via
Jun 18, 2005·Memórias do Instituto Oswaldo Cruz·Leonardo K TeixeiraJoão P B Viola
Aug 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Konstantin D TaganovDavid Baltimore
Aug 31, 2006·Methods in Enzymology·Alexander I SaeedJohn Quackenbush
Sep 21, 2006·International Journal of Immunogenetics·F E BertinettoA Amoroso
Nov 1, 2006·Biochemical Society Transactions·S M Abraham, A R Clark
Jan 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ryan M O'ConnellDavid Baltimore
Mar 24, 2007·PLoS Medicine·Effie W PetersdorfZhen Guo
Mar 24, 2007·PLoS Medicine·Chantal BaronClaude Perreault
Apr 28, 2007·Science·To-Ha ThaiKlaus Rajewsky
Apr 28, 2007·Science·Antony RodriguezAllan Bradley
May 28, 2008·Best Practice & Research. Clinical Haematology·A M Dickinson, E Holler
Mar 14, 2009·Lancet·James L M FerraraErnst Holler
Sep 3, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Isao TawaraPavan Reddy
Mar 13, 2012·Blood·Parvathi RanganathanRamiro Garzon
Oct 24, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jinhuan XuYicheng Zhang
Dec 4, 2012·Nucleic Acids Research·Irina RusinovaPaul J Hertzog
Dec 24, 2013·Blood·Carrie L KitkoSophie Paczesny
Feb 6, 2014·Clinical Transplantation·Lin-Na XieFan-Sheng Kong

❮ Previous
Next ❯

Methods Mentioned

BETA
density gradient centrifugation
ELISA
in vitro transcription
GTPase
irradiating
PCR
biopsies

Clinical Trials Mentioned

NCT01521039

Software Mentioned

PANTHER
Bioconductor
INTERFEROME
Array Tools
DAVID Bioinformatics
BRB

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Proceedings of the European Dialysis and Transplant Association
A Svejgaard, M Thomsen
© 2021 Meta ULC. All rights reserved